| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 2.50 | 2.40 | 2.60 | 2.50 | 2.50 | 2.50 | 30,198 | 07:45:21 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Diversified Industrial Holding | 12.3 | -11.3 | -3.5 | - | 5.94 |
Omega Diagnostics Group PLC Posting of Annual Report and confirmation of AGM
27/09/2022 7:00am
UK Regulatory (RNS & others)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2022 to May 2023
TIDMODX
RNS Number : 6996A
Omega Diagnostics Group PLC
27 September 2022
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Posting of Annual Report and confirmation of AGM
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, confirms that the Notice of Annual General Meeting ('AGM') along with the Annual Report and Accounts for the year ended 31 March 2022 has been posted to shareholders yesterday afternoon and will shortly be made available on the Company's website at:
https://www.omegadiagnostics.com/Investor-Relations/Corporate-Information/Annual-Report-and-Interim-Results
As previously announced, the AGM of the Company will be held on Wednesday 26 October 2022 at 11.00am at Poets House, St Mary's Street, Ely, CB7 4EY.
Contacts:
Omega Diagnostics Group PLC www.omegadx.com Jag Grewal, Chief Executive Officer via Walbrook PR Chris Lea, Chief Financial Officer finnCap Ltd Tel: 020 7220 0500 Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance) Alice Lane/Charlotte Sutcliffe (ECM) Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com Paul McManus / Sam Allen / Lianne Mob: 07980 541 893 / 07502 558 258 / Applegarth 07584 391 303
About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health.
www.omegadx.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACSPPUQPBUPPGQQ
(END) Dow Jones Newswires
September 27, 2022 02:00 ET (06:00 GMT)
1 Year Omega Diagnostics Chart |
1 Month Omega Diagnostics Chart |